|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-10-28
|
|
pubmed:abstractText |
Hemophilia B is an X-linked inherited disorder caused by the lack of functional factor IX (FIX). Currently, treatment of hemophilia B is performed by intravenous infusion of plasma-derived or recombinant FIX.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1538-7836
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 International Society on Thrombosis and Haemostasis.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1773-83
|
|
pubmed:dateRevised |
2011-5-10
|
|
pubmed:meshHeading |
pubmed-meshheading:20492477-Animals,
pubmed-meshheading:20492477-Blood Coagulation,
pubmed-meshheading:20492477-Disease Models, Animal,
pubmed-meshheading:20492477-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20492477-Factor IX,
pubmed-meshheading:20492477-Factor VIIIa,
pubmed-meshheading:20492477-Factor X,
pubmed-meshheading:20492477-Genetic Variation,
pubmed-meshheading:20492477-Hemophilia B,
pubmed-meshheading:20492477-Humans,
pubmed-meshheading:20492477-Male,
pubmed-meshheading:20492477-Mice,
pubmed-meshheading:20492477-Mice, Knockout,
pubmed-meshheading:20492477-Mutagenesis,
pubmed-meshheading:20492477-Partial Thromboplastin Time,
pubmed-meshheading:20492477-Recombinant Proteins,
pubmed-meshheading:20492477-Surface Plasmon Resonance
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Generation of a novel factor IX with augmented clotting activities in vitro and in vivo.
|
|
pubmed:affiliation |
Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
